Exponent CEO exercises options for 7,872 shares
Exponent Inc. CEO Catherine Corrigan exercised stock options to acquire 7,872 shares of common stock.
Rhea-AI Filing Summary
Exponent Inc. CEO Catherine Corrigan exercised stock options to acquire 7,872 shares of common stock. The options were exercised at an effective price of $25.405 per share, converting an incentive stock option grant into common shares.
Following this exercise, Corrigan directly holds 115,129 shares of Exponent common stock. The derivative position tied to this option grant was reduced to zero, and there was no reported same-day sale, indicating an exercise-and-hold transaction. A footnote notes the stock option became exercisable in four equal annual installments.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Incentive Stock Option (right to buy) | 7,872 | $0.00 | $0.00 |
| Exercise | Common Stock | 7,872 | $25.405 | $200K |
Footnotes (2)
- F1. The stock option becomes exercisable in four equal annual installments.
- F2. Not applicable.
Key Figures
Key Terms
Incentive Stock Option financial
Exercise or conversion of derivative security financial
Common Stock financial
stock option financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Exponent (EXPO) CEO Catherine Corrigan report on this Form 4?
At what price were the Exponent (EXPO) stock options exercised?
What happened to the CEO’s incentive stock option position at Exponent (EXPO)?
How did the Exponent (EXPO) stock option grant to the CEO vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.